Fundz

Syst Immune reported raising $7.18 Million in an initial SEC Form D filing, from an offering of $7.18 Million

PRIVATEJun 04, 2024

Amount Raised

$7.18 Million

$7.18 Million sold, per SEC Form D (first sale May 28, 2024)

Round Type

Venture

RedmondBiotechnologyTherapeuticsPharmaceuticalBiopharma

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as SystImmune that raised within 45 days of this round, from Fundz verified event records.

  • CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
  • CASI Pharmaceuticals raised $15M on June 26, 2024.
  • MyMD Pharmaceuticals raised $7M (Post-IPO Equity) on May 21, 2024.
  • MyMD Pharmaceuticals raised $27M on May 20, 2024.
  • MyMD Pharmaceuticals raised $15M on May 20, 2024.
  • Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.

Who to call at SystImmune, and when

A new round usually means SystImmune is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SystImmune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SystImmune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SystImmune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SystImmune

Location

Redmond, Washington, United States

About

Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune system to attack the tumor. We are a group of highly experienced immuno-oncology scientists utilizing several technology platforms to develop world class advanced antibody-based drug therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SystImmune raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for SystImmune's next move

See what Strategic adds

SystImmune raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.